Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMCA: Autologous Bone Marrow Cells for Autism
NCT01836562Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in Autism Spectrum Disorder (ASD), sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01836562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836562.